Corporate Headquarters
1900 Avenue of the Stars
Suite 310
Los Angeles, CA 90067
310.843.9300
Fax: 310.843.9304

 

Offices located nationwide, please call for a location nearest you

 

 

China Biopharmaceuticals Holdings, Inc. Retains Investment Bank Wellfleet Partners, Inc. and its Affiliates to Advise on Financings and Strategic Initiatives and Procure Bridge Funding.

January 6, 2005

COMPANY TO ADVANCE PLANS FOR GROWTH

NEW YORK, NY – China Biopharmaceuticals Holdings, Inc. (CBH) announced that it has retained Investment Bank Wellfleet Partners (WPs or Wellfleet) to advise the Company on financing opportunities as well as strategic initiatives, and subsequently closed a $500,000 Convertible Bridge Loan the first week in January 2005 through its broker-dealer relationship with WestPark Capital (WPC or WestPark).

“Having previously worked with many companies in the pharmaceutical services sector, we have developed a great understanding of the space, and we look forward to lending our expertise to the execution of the Company's strategic growth plans. This is our first foray into China and we thank our Senior Advisors Stan Wunderlich, for the introduction, and Dr. Robin Smith, for her superior efforts,” stated Mark I. Lev, Chairman and CEO of WPs.

"We have established a solid track record of performance in Asia, particularly China, and we look forward to assisting Wellfleet with its recently signed client,” stated Richard Rappaport, Chief Executive Officer at WestPark.

ABOUT CHINA BIOPHARMACEUTICALS HOLDINGS, INC.

China Biopharmaceuticals Holdings, Inc (CBH) is focused on developing and commercializing innovative drugs in China. The Company operates from a solid foundation of intergraded resources and capabilities including:

  • Advanced R&D capabilities unmatched in China ;
  • A full product pipeline of new drugs and proprietary drug discovery platforms;
  • Exclusive partnerships with the China Pharmaceutical University and China New Drug Development Center, through a joint venture drug development center and lab; and
  • Experienced management with a history of success in innovative drug development and commercialization in China .

CBH's integrated R&D technology platforms represent the most advanced drug discovery and development tools able to analyze the chemical compounds and natural substances of new drugs and traditional Chinese medicines. Based on proprietary gene-level biotechnology made possible by rapid advances in the post-genomics era, the platforms have high commercial value because of their ability to rapidly identify new chemical compounds and target them to specific diseases. It is anticipated that CBH will be a publicly traded company in January 2005.

ABOUT WELLFLEET PARTNERS, INC.

Wellfleet Partners, Inc. ( WPs or Wellfleet ) is a boutique investment and merchant banking, venture capital and financial services and consulting firm, which was founded by Mark I. Lev in early 1998. The Company's emphasis is to engage in a wide variety of corporate finance, venture capital, management consulting, short-term bridge loans and various fundraising activities for public and private companies (through affiliates) and corporate Investment Banking related activities to a broad range of emerging small to medium sized growth companies. In addition, through subsidiaries and/or affiliates, it offers financial and brokerage services and money management as well and has strategic partnerships in England, Europe and Florida and now Southern California (Los Angeles & San Diego) as well as Northern California (Palo Alto). WPs employees render their brokerage related activities through and are registered with WestPark Capital, Inc. For more information, please got to www.wellfleetpartners.com
Brochure/newsletter available upon request.

For further information, please contact:
Michelle-Lee Cona – Michelle@Wellfleetpartners.com (re WPs )
Stanley Wunderlich – Swunderlich@Wellfleetpartners.com (re CBH )
Wellfleet Partners, Inc. (212) 714-0400, Fax (212) 714-1835
1Penn Plaza , Suite 2032
New York , NY 10119
www.wellfleetpartners.com

 

ABOUT WESTPARK CAPITAL, INC.

WestPark Capital, Inc. is a full service investment banking and securities brokerage firm that serves the needs of both private and public companies worldwide, as well as individual and institutional investors. WestPark is committed to forging lasting partnerships with emerging growth companies and the investors who back them. WestPark's approach is to provide customized financial solutions for virtually any need. A complete range of investment banking and brokerage services is available to corporate and individual clients. WestPark's corporate finance professionals have the depth of experience and resources to create integrated financing solutions for both private and public marketplaces. Additionally, WestPark offers an exceptional array of private client services through its dedicated group of financial consultants. WestPark Capital understands the importance of strong relationships in today's dynamic business environment and welcomes the opportunity to leverage this power into success for its customers. For more information visit www.wpcapital.com .

 

For further information, please contact:
Richard Rappaport
Anthony Pintsopoulos
WestPark Capital, Inc. (310) 843-9300
1900 Avenue of the Stars, Suite 310
Los Angeles, CA 90067
http://www.wpcapital.com

International Locations*

Beijing, China

Shanghai, China

Hong Kong

Taipei, Taiwan

Canada